> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bioventus Paying $3.6 Million for False Claims Violations
- URL: https://www.fdaweb.com/bioventus-paying-3-6-million-for-false-claims-violations/
- Published: 2021-03-02T12:00:00.000Z
- Updated: 2026-09-14T16:49:00.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5148780

The Department of Justice says global medical technology company Bioventus is paying over $3.6 million to resolve allegations that it violated the False Claims Act by submitting improperly completed certificates of medical necessity for medically unnecessary devices from 10/1/12 through 12/31/18\. A department [statement](https://www.justice.gov/usao-mdnc/pr/bioventus-agrees-pay-more-36-million-resolve-false-claims-act-violations?ref=fdaweb.com) says Bioventus made a written self-disclosure on 11/30/18 relating to its Exogen device, an ultrasonic bone growth stimulator. The company reported it had discovered that its sales representatives were sometimes completing a section of the medical necessity certificate that is to be completed by treating doctors.

The department says the company fully cooperated with the government’s investigation into the self-disclosure.